Michael S. Richman's most recent trade in Nextcure Inc was a trade of 305,500 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nextcure Inc | Michael S. Richman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 305,500 | 305,500 | - | - | Employee Stock Option (Right to Buy) | |
| Nextcure Inc | Michael S. Richman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 244,400 | 244,400 | - | - | Employee Stock Option (Right to Buy) | |
| Nextcure Inc | Michael S. Richman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 305,500 | 305,500 | - | - | Employee Stock Option (Right to Buy) | |
| Nextcure Inc | Michael S. Richman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 309,000 | 309,000 | - | - | Employee Stock Option (Right to Buy) | |
| Nextcure Inc | Michael S. Richman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 262,400 | 262,400 | - | - | Employee Stock Option (Right to Buy) | |
| Pieris Pharmaceuticals Inc | Michael S. Richman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Nextcure Inc | Michael S. Richman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 300,000 | 300,000 | - | - | Employee Stock Option (Right to Buy) |